The approval Journey Medical received from FDA for Emrosi makes DERM an exciting stock. Click here to read more.

The ticketing software industry is constantly advancing, driven by ongoing innovations and developments. The event ticketing ...

Michael Ryskin, an analyst from Bank of America Securities, maintained the Buy rating on Thermo Fisher (TMO – Research Report). The associated ...

ISLAMABAD: The Federal Board of Revenue (FBR) issued new procedures on Wednesday to streamline licensing, issuing electronic sales tax invoices, and integrating registered persons into the electronic ...

In a report released today, Hamed Khorsand from BWS Financial maintained a Hold rating on Hawkins (HWKN – Research Report), with a price target ...

If you’ve been keeping an eye on the cryptocurrency community, it’s hard to ignore the buzz surrounding Qarden’s upcoming ...

Earnings Call Transcript January 30, 2025 Sanofi misses on earnings expectations. Reported EPS is $0.7 EPS, expectations were ...

The holiday season and its aftermath puts a particular focus on returns and refunds, but it's a year-round retail sector ...

Q4 2024 Earnings Conference Call January 31, 2025 8:00 AM ETCompany ParticipantsGreg Riddle - IRMark Costa - Board ...

Cloud ERP solutions provider Acumatica announced several updates and enhancements for 2025 that align with the company's new ...